7 senior director clinical development jobs found in Boston

At Merck, known as MSD outside of the United States and Canada, we are unified around our purpose: We use the power of leading-edge science to save and improve lives around the world. 

Vertex is a global biotechnology company that invests in scientific innovation to create transformative medicines for people with serious diseases. The company has three approved medicines that treat the underlying cause of cystic fibrosis (CF) – a rare, life-threatening genetic disease — and has several ongoing clinical and research programs in CF. Beyond CF, Vertex has a robust pipeline of investigational medicines in other serious diseases where it has deep insight into causal human biology, such as sickle cell disease, beta thalassemia, pain, alpha-1 antitrypsin deficiency, Duchenne muscular dystrophy and APOL1-mediated kidney disease.

Vertex is a global biotechnology company that invests in scientific innovation to create transformative medicines for people with serious diseases. The company has three approved medicines that treat the underlying cause of cystic fibrosis (CF) – a rare, life-threatening genetic disease — and has several ongoing clinical and research programs in CF. Beyond CF, Vertex has a robust pipeline of investigational medicines in other serious diseases where it has deep insight into causal human biology, such as sickle cell disease, beta thalassemia, pain, alpha-1 antitrypsin deficiency, Duchenne muscular dystrophy and APOL1-mediated kidney disease.

Vertex is a global biotechnology company that invests in scientific innovation to create transformative medicines for people with serious diseases. The company has three approved medicines that treat the underlying cause of cystic fibrosis (CF) – a rare, life-threatening genetic disease — and has several ongoing clinical and research programs in CF. Beyond CF, Vertex has a robust pipeline of investigational medicines in other serious diseases where it has deep insight into causal human biology, such as sickle cell disease, beta thalassemia, pain, alpha-1 antitrypsin deficiency, Duchenne muscular dystrophy and APOL1-mediated kidney disease.

Working at Alexion is an experience like no other. With a focus on devastating and rare diseases, each endeavor is urgent and every day counts. You’ll have the opportunity to work on one of the most robust and exciting rare disease pipelines in the biopharmaceutical industry, which includes dozens of diverse preclinical programs across a range of therapeutic modalities. Ground-breaking innovation, life-saving therapies and a promising pipeline, all driven by a team with a shared sense of purpose and dedication – that’s Alexion. Join us to achieve the impossible and do what’s never been done before.

Working at Alexion is an experience like no other. With a focus on devastating and rare diseases, each endeavor is urgent and every day counts. You’ll have the opportunity to work on one of the most robust and exciting rare disease pipelines in the biopharmaceutical industry, which includes dozens of diverse preclinical programs across a range of therapeutic modalities. Ground-breaking innovation, life-saving therapies and a promising pipeline, all driven by a team with a shared sense of purpose and dedication – that’s Alexion. Join us to achieve the impossible and do what’s never been done before.

Working at Alexion is an experience like no other. With a focus on devastating and rare diseases, each endeavor is urgent and every day counts. You’ll have the opportunity to work on one of the most robust and exciting rare disease pipelines in the biopharmaceutical industry, which includes dozens of diverse preclinical programs across a range of therapeutic modalities. Ground-breaking innovation, life-saving therapies and a promising pipeline, all driven by a team with a shared sense of purpose and dedication – that’s Alexion. Join us to achieve the impossible and do what’s never been done before.